Olanzapine versus risperidone: weight gain and elevation of serum triglyceride levels.
Garyfallos
George
G
The B' University Department of Psychiatry, Aristotelian University of Thessaloniki, and Community Mental Health Center, 20 Papadopoulou Str-Sikies, 56625 Thessaloniki, Greece. anakar@med.auth.gr
Dimelis
Dimos
D
Kouniakis
Philippos
P
Sidiropoulos
Nikos
N
Karastergiou
Anastasia
A
Lavrentiadis
Grigoris
G
Giouzepas
John
J
Fokas
Kostas
K
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D000077152:Olanzapine; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000097:blood / Q000188:drug therapy*; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D014280:Triglycerides / Q000097:blood*; D015430:Weight Gain / Q000187:drug effects*
D014150:Antipsychotic Agents; D014280:Triglycerides; D001569:Benzodiazepines; D002784:Cholesterol; D018967:Risperidone; D000077152:Olanzapine